Yoriko Murata
- Hepatology top 5%
- Obstetrics and Gynecology top 10%
- Sensory Systems top 10%
- Olfactory and Sensory Function Studies 3
- Reproductive Medicine top 10%
-
- MRI in cancer diagnosis 6
- Medical Imaging Techniques and Applications 3
-
- Breast Cancer Treatment Studies 5
- Cancer, Lipids, and Metabolism 3
-
- Breast Lesions and Carcinomas 5
-
- Liver Disease Diagnosis and Treatment 4
- Meningioma and schwannoma management 3
- Co-authors
- Shoji YōshidaAkihito NishiokaToru IijimaYuji HidakaNobuyuki AminoHirokazu TadaYasuhiro OgawaSatoshi Itoh
- Partner nations
- JapanUnited States
In The Last Decade
Yoriko Murata
42 papers receiving 630 citations
Peers
Comparison fields: 5 of 85
- Hepatology 133
- Obstetrics and Gynecology 70
- Endocrinology, Diabetes and Metabolism 136
- Sensory Systems 32
- Reproductive Medicine 43
Countries citing papers authored by Yoriko Murata
This map shows the geographic impact of Yoriko Murata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoriko Murata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoriko Murata more than expected).
Fields of papers citing papers by Yoriko Murata
This network shows the impact of papers produced by Yoriko Murata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoriko Murata. The network helps show where Yoriko Murata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoriko Murata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2019 | 1 | |
| 3 | 2019 | 8 | |
| 4 | 2014 | 2 | |
| 5 | [A case of HER2-positive gastric cancer successfully treated with trastuzumab plus capecitabine plus cisplatin chemotherapy as third-line treatment]. | 2013 | 0 |
| 6 | 2011 | 1 | |
| 7 | 2008 | 20 | |
| 8 | 2007 | 7 | |
| 9 | 2006 | 2 | |
| 10 | 2006 | 4 | |
| 11 | Relationship between hormonal receptors, HER-2, p53 protein, Bcl-2, and MIB-1 status and the antitumor effects of neoadjuvant anthracycline-based chemotherapy in invasive breast cancer patients. | 2005 | 18 |
| 12 | 2005 | 7 | |
| 13 | 2005 | 22 | |
| 14 | 2004 | 3 | |
| 15 | 2004 | 9 | |
| 16 | 2002 | 2 | |
| 17 | 2001 | 90 | |
| 18 | 2000 | 1 | |
| 19 | 1998 | 44 | |
| 20 | 1998 | 1 |
About Yoriko Murata
Yoriko Murata is a scholar working on Sensory Systems, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 44 papers that have together received 646 indexed citations. Recurring topics across this work include MRI in cancer diagnosis (6 papers), Breast Cancer Treatment Studies (5 papers), Breast Lesions and Carcinomas (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Medical Imaging Techniques and Applications (3 papers), Cancer, Lipids, and Metabolism (3 papers), Meningioma and schwannoma management (3 papers) and Olfactory and Sensory Function Studies (3 papers). The work is most often cited by research in Hepatology (133 citations), Obstetrics and Gynecology (70 citations) and Endocrinology, Diabetes and Metabolism (136 citations). Yoriko Murata has collaborated with scholars based in Japan and United States. Frequent co-authors include Shoji Yōshida, Akihito Nishioka, Toru Iijima, Yuji Hidaka, Nobuyuki Amino, Hirokazu Tada, Yasuhiro Ogawa, Satoshi Itoh, Yasushi Fujiwara and Kazunori Kubota.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.